The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide

The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide

Abstract Background In patients with bone metastatic castration-resistant prostate cancer (bmCRPC) on systemic treatment, it is difficult to differentiate between continuous rise of prostate specific antigen (PSA) representing progression, and PSA-surge, which is followed by clinical response or sta...

Full description

Bibliographic Details
Main Authors: Renata Poteska, Kambiz Rahbar, Axel Semjonow, Andres Jan Schrader, Martin Boegemann, Katrin Schlack
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Cancer
Subjects:
bmCRPC
Enzalutamide
Prognosis
Prostate specific antigen
Alkaline phosphatase
Lactate dehydrogenase
Online Access:https://doi.org/10.1186/s12885-022-09483-7

Internet

https://doi.org/10.1186/s12885-022-09483-7

Similar Items